No Data
No Data
Biomea Fusion, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Biomea Fusion Inc - Franco Valle Resigns as CFO of Biomea Fusion
Express News | Biomea Fusion To Feature Presentations At 18th International Conference on Advanced Technologies & Treatments for Diabetes Mar. 18-20
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes
Biomea Fusion Price Target Cut to $16.00/Share From $128.00 by D. Boral Capital
D. Boral Capital Initiates Biomea Fusion(BMEA.US) With Buy Rating, Announces Target Price $16